Founded in 2008 by philanthropist A. Alfred Taubman, the institute aims to empower medical scientists to expand the boundaries of discovery, to develop new therapies for disease and to alleviate human suffering.


Covid-19 and Addiction: The Science of Relapse in a Pandemic

COVID-19 has generated a public health crisis that affects every household. And it’s exacerbating another widespread public health crisis that already was ongoing when the pandemic arrived: addiction and other mental health problems. During the pandemic, complications from substance use, and overdose deaths, have been increasing even faster than before. At the same time, it…

Read more

Taubman Scholar reviews possible blood test to detect Alzheimer’s

Earlier, less intrusive and less costly tests for Alzheimer’s disease would allow doctors to try intervention therapies earlier in the disorder’s development, in hopes of slowing or curbing progression of the disease. Taubman Scholar Henry Paulson, MD, PhD, was interviewed recently about some new blood tests making the news among dementia researchers. Read what he…

Read more

Project Review Webinar: Transplantation Immunology

Join Michigan Medicine’s Daniel Goldstein, MD and renowned human transplantation immunology researchers October 12 at 9 am-Noon for an update on their Taubman Institute Innovation Project (TIIP) that aims to refine the use of immune-suppression drugs in solid organ transplant patients. Dr. Goldstein heads a team of three Michigan Medicine primary investigators in this TIIP,…

Read more